Global Antibody Market Insights and Forecast to 2027

Global Antibody Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Antibody Market Size Growth Rate by Type
1.4.2 IgM
1.4.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Market by Application
1.3.1 Global Antibody Market Size Growth Rate by Application
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody Sales Estimates and Forecasts 2016-2027
2.2 Global Antibody Revenue Estimates and Forecasts 2016-2027
2.3 Global Antibody Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Antibody Regions by Sales
2.4.1 Global Top Antibody Regions by Sales (2016-2021)
2.4.2 Global Top Antibody Regions by Sales (2022-2027)
2.5 Global Top Antibody Regions by Revenue
2.5.1 Global Top Antibody Regions by Revenue (2016-2021)
2.5.2 Global Top Antibody Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibody Sales by Manufacturers
3.1.1 Global Top Antibody Manufacturers by Sales (2016-2021)
3.1.2 Global Top Antibody Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Antibody Sales in 2020
3.2 Global Antibody Revenue by Manufacturers
3.2.1 Global Top Antibody Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Antibody Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Antibody Revenue in 2020
3.3 Global Antibody Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibody Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibody Sales by Type
4.1.1 Global Antibody Historical Sales by Type (2016-2021)
4.1.2 Global Antibody Forecasted Sales by Type (2022-2027)
4.1.3 Global Antibody Sales Market Share by Type (2016-2027)
4.2 Global Antibody Revenue by Type
4.2.1 Global Antibody Historical Revenue by Type (2016-2021)
4.2.2 Global Antibody Forecasted Revenue by Type (2022-2027)
4.2.3 Global Antibody Revenue Market Share by Type (2016-2027)
4.3 Global Antibody Price by Type
4.3.1 Global Antibody Price by Type (2016-2021)
4.3.2 Global Antibody Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Antibody Sales by Application
5.1.1 Global Antibody Historical Sales by Application (2016-2021)
5.1.2 Global Antibody Forecasted Sales by Application (2022-2027)
5.1.3 Global Antibody Sales Market Share by Application (2016-2027)
5.2 Global Antibody Revenue by Application
5.2.1 Global Antibody Historical Revenue by Application (2016-2021)
5.2.2 Global Antibody Forecasted Revenue by Application (2022-2027)
5.2.3 Global Antibody Revenue Market Share by Application (2016-2027)
5.3 Global Antibody Price by Application
5.3.1 Global Antibody Price by Application (2016-2021)
5.3.2 Global Antibody Price Forecast by Application (2022-2027)
6 North America
6.1 North America Antibody Market Size by Type
6.1.1 North America Antibody Sales by Type (2016-2027)
6.1.2 North America Antibody Revenue by Type (2016-2027)
6.2 North America Antibody Market Size by Application
6.2.1 North America Antibody Sales by Application (2016-2027)
6.2.2 North America Antibody Revenue by Application (2016-2027)
6.3 North America Antibody Market Size by Country
6.3.1 North America Antibody Sales by Country (2016-2027)
6.3.2 North America Antibody Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antibody Market Size by Type
7.1.1 Europe Antibody Sales by Type (2017-2027)
7.1.2 Europe Antibody Revenue by Type (2017-2027)
7.2 Europe Antibody Market Size by Application
7.2.1 Europe Antibody Sales by Application (2017-2027)
7.2.2 Europe Antibody Revenue by Application (2017-2027)
7.3 Europe Antibody Market Size by Country
7.3.1 Europe Antibody Sales by Country (2017-2027)
7.3.2 Europe Antibody Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibody Market Size by Type
8.1.1 Asia Pacific Antibody Sales by Type (2018-2027)
8.1.2 Asia Pacific Antibody Revenue by Type (2018-2027)
8.2 Asia Pacific Antibody Market Size by Application
8.2.1 Asia Pacific Antibody Sales by Application (2018-2027)
8.2.2 Asia Pacific Antibody Revenue by Application (2018-2027)
8.3 Asia Pacific Antibody Market Size by Region
8.3.1 Asia Pacific Antibody Sales by Region (2018-2027)
8.3.2 Asia Pacific Antibody Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antibody Market Size by Type
9.1.1 Latin America Antibody Sales by Type (2019-2027)
9.1.2 Latin America Antibody Revenue by Type (2019-2027)
9.2 Latin America Antibody Market Size by Application
9.2.1 Latin America Antibody Sales by Application (2019-2027)
9.2.2 Latin America Antibody Revenue by Application (2019-2027)
9.3 Latin America Antibody Market Size by Country
9.3.1 Latin America Antibody Sales by Country (2019-2027)
9.3.2 Latin America Antibody Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Antibody Market Size by Type
6.1.1 Middle East and Africa Antibody Sales by Type (2016-2027)
6.1.2 Middle East and Africa Antibody Revenue by Type (2016-2027)
6.2 Middle East and Africa Antibody Market Size by Application
6.2.1 Middle East and Africa Antibody Sales by Application (2016-2027)
6.2.2 Middle East and Africa Antibody Revenue by Application (2016-2027)
6.3 Middle East and Africa Antibody Market Size by Country
6.3.1 Middle East and Africa Antibody Sales by Country (2016-2027)
6.3.2 Middle East and Africa Antibody Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Roche Antibody Product Description
11.1.5 Roche Related Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Johnson & Johnson Antibody Product Description
11.2.5 Johnson & Johnson Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Merck Antibody Product Description
11.3.5 Merck Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Novartis Antibody Product Description
11.4.5 Novartis Related Developments
11.5 AbbVie
11.5.1 AbbVie Corporation Information
11.5.2 AbbVie Overview
11.5.3 AbbVie Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 AbbVie Antibody Product Description
11.5.5 AbbVie Related Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Overview
11.6.3 Amgen Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Amgen Antibody Product Description
11.6.5 Amgen Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Pfizer Antibody Product Description
11.7.5 Pfizer Related Developments
11.8 Bayer
11.8.1 Bayer Corporation Information
11.8.2 Bayer Overview
11.8.3 Bayer Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Bayer Antibody Product Description
11.8.5 Bayer Related Developments
11.9 Lilly
11.9.1 Lilly Corporation Information
11.9.2 Lilly Overview
11.9.3 Lilly Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Lilly Antibody Product Description
11.9.5 Lilly Related Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Overview
11.10.3 Bristol-Myers Squibb Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Bristol-Myers Squibb Antibody Product Description
11.10.5 Bristol-Myers Squibb Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Roche Antibody Product Description
11.1.5 Roche Related Developments
11.12 Biogen
11.12.1 Biogen Corporation Information
11.12.2 Biogen Overview
11.12.3 Biogen Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Biogen Product Description
11.12.5 Biogen Related Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Corporation Information
11.13.2 AstraZeneca Overview
11.13.3 AstraZeneca Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 AstraZeneca Product Description
11.13.5 AstraZeneca Related Developments
11.14 Sanofi
11.14.1 Sanofi Corporation Information
11.14.2 Sanofi Overview
11.14.3 Sanofi Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Sanofi Product Description
11.14.5 Sanofi Related Developments
11.15 Alexion Pharmaceuticals
11.15.1 Alexion Pharmaceuticals Corporation Information
11.15.2 Alexion Pharmaceuticals Overview
11.15.3 Alexion Pharmaceuticals Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Alexion Pharmaceuticals Product Description
11.15.5 Alexion Pharmaceuticals Related Developments
11.16 Seattle Genetics
11.16.1 Seattle Genetics Corporation Information
11.16.2 Seattle Genetics Overview
11.16.3 Seattle Genetics Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Seattle Genetics Product Description
11.16.5 Seattle Genetics Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Antibody Value Chain Analysis
12.2 Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibody Production Mode & Process
12.4 Antibody Sales and Marketing
12.4.1 Antibody Sales Channels
12.4.2 Antibody Distributors
12.5 Antibody Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibody Industry Trends
13.2 Antibody Market Drivers
13.3 Antibody Market Challenges
13.4 Antibody Market Restraints
14 Key Findings in The Global Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antibody Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of IgM
Table 3. Major Manufacturers of IgG
Table 4. Major Manufacturers of IgA
Table 5. Major Manufacturers of Other
Table 6. Global Antibody Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Antibody Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Antibody Sales by Region (2016-2021) & (MT)
Table 9. Global Antibody Sales Market Share by Region (2016-2021)
Table 10. Global Antibody Sales by Region (2016-2021) & (MT)
Table 11. Global Antibody Sales Market Share by Region (2022-2027)
Table 12. Global Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Antibody Revenue Market Share by Region (2016-2021)
Table 14. Global Antibody Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Antibody Revenue Market Share by Region (2022-2027)
Table 16. Global Antibody Sales by Manufacturers (2016-2021) & (MT)
Table 17. Global Antibody Sales Share by Manufacturers (2016-2021)
Table 18. Global Antibody Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Antibody Revenue Share by Manufacturers (2016-2021)
Table 20. Antibody Price by Manufacturers 2016-2021 (USD/MT)
Table 21. Global Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody as of 2020)
Table 23. Antibody Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antibody Product Offered
Table 25. Date of Manufacturers Enter into Antibody Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antibody Sales by Type (2016-2021) & (MT)
Table 28. Global Antibody Sales by Type (2022-2027) & (MT)
Table 29. Global Antibody Sales Share by Type (2016-2021)
Table 30. Global Antibody Sales Share by Type (2022-2027)
Table 31. Global Antibody Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Antibody Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Antibody Revenue Share by Type (2016-2021)
Table 34. Global Antibody Revenue Share by Type (2022-2027)
Table 35. Antibody Price by Type (2016-2021) & (USD/MT)
Table 36. Global Antibody Price Forecast by Type (2022-2027) & (USD/MT)
Table 37. Global Antibody Sales by Application (2016-2021) & (MT)
Table 38. Global Antibody Sales by Application (2022-2027) & (MT)
Table 39. Global Antibody Sales Share by Application (2016-2021)
Table 40. Global Antibody Sales Share by Application (2022-2027)
Table 41. Global Antibody Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Antibody Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Antibody Revenue Share by Application (2016-2021)
Table 44. Global Antibody Revenue Share by Application (2022-2027)
Table 45. Antibody Price by Application (2016-2021) & (USD/MT)
Table 46. Global Antibody Price Forecast by Application (2022-2027) & (USD/MT)
Table 47. North America Antibody Sales by Type (2016-2021) & (MT)
Table 48. North America Antibody Sales by Type (2022-2027) & (MT)
Table 49. North America Antibody Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Antibody Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Antibody Sales by Application (2016-2021) & (MT)
Table 52. North America Antibody Sales by Application (2022-2027) & (MT)
Table 53. North America Antibody Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Antibody Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Antibody Sales by Country (2016-2021) & (MT)
Table 56. North America Antibody Sales by Country (2022-2027) & (MT)
Table 57. North America Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Antibody Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Antibody Sales by Type (2016-2021) & (MT)
Table 60. Europe Antibody Sales by Type (2022-2027) & (MT)
Table 61. Europe Antibody Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Antibody Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Antibody Sales by Application (2016-2021) & (MT)
Table 64. Europe Antibody Sales by Application (2022-2027) & (MT)
Table 65. Europe Antibody Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Antibody Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Antibody Sales by Country (2016-2021) & (MT)
Table 68. Europe Antibody Sales by Country (2022-2027) & (MT)
Table 69. Europe Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Antibody Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Antibody Sales by Type (2016-2021) & (MT)
Table 72. Asia Pacific Antibody Sales by Type (2022-2027) & (MT)
Table 73. Asia Pacific Antibody Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Antibody Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Antibody Sales by Application (2016-2021) & (MT)
Table 76. Asia Pacific Antibody Sales by Application (2022-2027) & (MT)
Table 77. Asia Pacific Antibody Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Antibody Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Antibody Sales by Region (2016-2021) & (MT)
Table 80. Asia Pacific Antibody Sales by Region (2022-2027) & (MT)
Table 81. Asia Pacific Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Antibody Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Antibody Sales by Type (2016-2021) & (MT)
Table 84. Latin America Antibody Sales by Type (2022-2027) & (MT)
Table 85. Latin America Antibody Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Antibody Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Antibody Sales by Application (2016-2021) & (MT)
Table 88. Latin America Antibody Sales by Application (2022-2027) & (MT)
Table 89. Latin America Antibody Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Antibody Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Antibody Sales by Country (2016-2021) & (MT)
Table 92. Latin America Antibody Sales by Country (2022-2027) & (MT)
Table 93. Latin America Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Antibody Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Antibody Sales by Type (2016-2021) & (MT)
Table 96. Middle East and Africa Antibody Sales by Type (2022-2027) & (MT)
Table 97. Middle East and Africa Antibody Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Antibody Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Antibody Sales by Application (2016-2021) & (MT)
Table 100. Middle East and Africa Antibody Sales by Application (2022-2027) & (MT)
Table 101. Middle East and Africa Antibody Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Antibody Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Antibody Sales by Country (2016-2021) & (MT)
Table 104. Middle East and Africa Antibody Sales by Country (2022-2027) & (MT)
Table 105. Middle East and Africa Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Antibody Revenue by Country (2022-2027) & (US$ Million)
Table 107. Roche Corporation Information
Table 108. Roche Description and Major Businesses
Table 109. Roche Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 110. Roche Antibody Product
Table 111. Roche Recent Developments
Table 112. Johnson & Johnson Corporation Information
Table 113. Johnson & Johnson Description and Major Businesses
Table 114. Johnson & Johnson Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 115. Johnson & Johnson Antibody Product
Table 116. Johnson & Johnson Recent Developments
Table 117. Merck Corporation Information
Table 118. Merck Description and Major Businesses
Table 119. Merck Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 120. Merck Antibody Product
Table 121. Merck Recent Developments
Table 122. Novartis Corporation Information
Table 123. Novartis Description and Major Businesses
Table 124. Novartis Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 125. Novartis Antibody Product
Table 126. Novartis Recent Developments
Table 127. AbbVie Corporation Information
Table 128. AbbVie Description and Major Businesses
Table 129. AbbVie Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 130. AbbVie Antibody Product
Table 131. AbbVie Recent Developments
Table 132. Amgen Corporation Information
Table 133. Amgen Description and Major Businesses
Table 134. Amgen Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 135. Amgen Antibody Product
Table 136. Amgen Recent Developments
Table 137. Pfizer Corporation Information
Table 138. Pfizer Description and Major Businesses
Table 139. Pfizer Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 140. Pfizer Antibody Product
Table 141. Pfizer Recent Developments
Table 142. Bayer Corporation Information
Table 143. Bayer Description and Major Businesses
Table 144. Bayer Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 145. Bayer Antibody Product
Table 146. Bayer Recent Developments
Table 147. Lilly Corporation Information
Table 148. Lilly Description and Major Businesses
Table 149. Lilly Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 150. Lilly Antibody Product
Table 151. Lilly Recent Developments
Table 152. Bristol-Myers Squibb Corporation Information
Table 153. Bristol-Myers Squibb Description and Major Businesses
Table 154. Bristol-Myers Squibb Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 155. Bristol-Myers Squibb Antibody Product
Table 156. Bristol-Myers Squibb Recent Developments
Table 157. GlaxoSmithKline Corporation Information
Table 158. GlaxoSmithKline Description and Major Businesses
Table 159. GlaxoSmithKline Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 160. GlaxoSmithKline Antibody Product
Table 161. GlaxoSmithKline Recent Developments
Table 162. Biogen Corporation Information
Table 163. Biogen Description and Major Businesses
Table 164. Biogen Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 165. Biogen Antibody Product
Table 166. Biogen Recent Developments
Table 167. AstraZeneca Corporation Information
Table 168. AstraZeneca Description and Major Businesses
Table 169. AstraZeneca Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 170. AstraZeneca Antibody Product
Table 171. AstraZeneca Recent Developments
Table 172. Sanofi Corporation Information
Table 173. Sanofi Description and Major Businesses
Table 174. Sanofi Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 175. Sanofi Antibody Product
Table 176. Sanofi Recent Developments
Table 177. Alexion Pharmaceuticals Corporation Information
Table 178. Alexion Pharmaceuticals Description and Major Businesses
Table 179. Alexion Pharmaceuticals Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 180. Alexion Pharmaceuticals Antibody Product
Table 181. Alexion Pharmaceuticals Recent Developments
Table 182. Seattle Genetics Corporation Information
Table 183. Seattle Genetics Description and Major Businesses
Table 184. Seattle Genetics Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 185. Seattle Genetics Antibody Product
Table 186. Seattle Genetics Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Antibody Distributors List
Table 190. Antibody Customers List
Table 191. Antibody Market Trends
Table 192. Antibody Market Drivers
Table 193. Antibody Market Challenges
Table 194. Antibody Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Product Picture
Figure 2. Global Antibody Market Share by Type in 2020 & 2027
Figure 3. IgM Product Picture
Figure 4. IgG Product Picture
Figure 5. IgA Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antibody Sales Market Share by Application in 2020 & 2027
Figure 8. Therapeutic
Figure 9. Research
Figure 10. Diagnostic
Figure 11. Antibody Report Years Considered
Figure 12. Global Antibody Sales 2016-2027 (MT)
Figure 13. Global Antibody Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Antibody Revenue 2016-2027 (US$ Million)
Figure 15. Global Antibody Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Antibody Sales Market Share by Region (2016-2021)
Figure 17. Global Antibody Sales Market Share by Region (2022-2027)
Figure 18. North America Antibody Sales YoY (2016-2027) & (MT)
Figure 19. North America Antibody Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Antibody Sales YoY (2016-2027) & (MT)
Figure 21. Europe Antibody Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Antibody Sales YoY (2016-2027) & (MT)
Figure 23. Asia-Pacific Antibody Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Antibody Sales YoY (2016-2027) & (MT)
Figure 25. Latin America Antibody Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Antibody Sales YoY (2016-2027) & (MT)
Figure 27. Middle East & Africa Antibody Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Antibody Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Antibody Revenue in 2020
Figure 30. Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Antibody Sales Market Share by Type (2016-2027)
Figure 32. Global Antibody Revenue Market Share by Type (2016-2027)
Figure 33. Global Antibody Sales Market Share by Application (2016-2027)
Figure 34. Global Antibody Revenue Market Share by Application (2016-2027)
Figure 35. North America Antibody Sales Market Share by Type (2016-2027)
Figure 36. North America Antibody Revenue Market Share by Type (2016-2027)
Figure 37. North America Antibody Sales Market Share by Application (2016-2027)
Figure 38. North America Antibody Revenue Market Share by Application (2016-2027)
Figure 39. North America Antibody Sales Share by Country (2016-2027)
Figure 40. North America Antibody Revenue Share by Country (2016-2027)
Figure 41. U.S. Antibody Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Antibody Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Antibody Sales Market Share by Type (2016-2027)
Figure 44. Europe Antibody Revenue Market Share by Type (2016-2027)
Figure 45. Europe Antibody Sales Market Share by Application (2016-2027)
Figure 46. Europe Antibody Revenue Market Share by Application (2016-2027)
Figure 47. Europe Antibody Sales Share by Country (2016-2027)
Figure 48. Europe Antibody Revenue Share by Country (2016-2027)
Figure 49. Germany Antibody Revenue (2016-2027) & (US$ Million)
Figure 50. France Antibody Revenue (2016-2027) & (US$ Million)
Figure 51. U.K. Antibody Revenue (2016-2027) & (US$ Million)
Figure 52. Italy Antibody Revenue (2016-2027) & (US$ Million)
Figure 53. Russia Antibody Revenue (2016-2027) & (US$ Million)
Figure 54. Asia Pacific Antibody Sales Market Share by Type (2016-2027)
Figure 55. Asia Pacific Antibody Revenue Market Share by Type (2016-2027)
Figure 56. Asia Pacific Antibody Sales Market Share by Application (2016-2027)
Figure 57. Asia Pacific Antibody Revenue Market Share by Application (2016-2027)
Figure 58. Asia Pacific Antibody Sales Share by Region (2016-2027)
Figure 59. Asia Pacific Antibody Revenue Share by Region (2016-2027)
Figure 60. China Antibody Revenue (2016-2027) & (US$ Million)
Figure 61. Japan Antibody Revenue (2016-2027) & (US$ Million)
Figure 62. South Korea Antibody Revenue (2016-2027) & (US$ Million)
Figure 63. India Antibody Revenue (2016-2027) & (US$ Million)
Figure 64. Australia Antibody Revenue (2016-2027) & (US$ Million)
Figure 65. Taiwan Antibody Revenue (2016-2027) & (US$ Million)
Figure 66. Indonesia Antibody Revenue (2016-2027) & (US$ Million)
Figure 67. Thailand Antibody Revenue (2016-2027) & (US$ Million)
Figure 68. Malaysia Antibody Revenue (2016-2027) & (US$ Million)
Figure 69. Philippines Antibody Revenue (2016-2027) & (US$ Million)
Figure 70. Latin America Antibody Sales Market Share by Type (2016-2027)
Figure 71. Latin America Antibody Revenue Market Share by Type (2016-2027)
Figure 72. Latin America Antibody Sales Market Share by Application (2016-2027)
Figure 73. Latin America Antibody Revenue Market Share by Application (2016-2027)
Figure 74. Latin America Antibody Sales Share by Country (2016-2027)
Figure 75. Latin America Antibody Revenue Share by Country (2016-2027)
Figure 76. Mexico Antibody Revenue (2016-2027) & (US$ Million)
Figure 77. Brazil Antibody Revenue (2016-2027) & (US$ Million)
Figure 78. Argentina Antibody Revenue (2016-2027) & (US$ Million)
Figure 79. Middle East and Africa Antibody Sales Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Antibody Revenue Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Antibody Sales Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Antibody Revenue Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Antibody Sales Share by Country (2016-2027)
Figure 84. Middle East and Africa Antibody Revenue Share by Country (2016-2027)
Figure 85. Turkey Antibody Revenue (2016-2027) & (US$ Million)
Figure 86. Saudi Arabia Antibody Revenue (2016-2027) & (US$ Million)
Figure 87. U.A.E Antibody Revenue (2016-2027) & (US$ Million)
Figure 88. Antibody Value Chain
Figure 89. Antibody Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Fig

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antibody Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136

According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Antibody Production Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121

Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......

Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......

Global Antibody Production Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......

Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Monoclonal Antibody Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92

This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......

Monoclonal Antibody Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73

This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......

Monoclonal Antibody Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219

China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs